Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 19Ovarian Neoplasms 11Neoplasms 7Liposarcoma 7Leiomyosarcoma 7Neoplasm Metastasis 4Sarcoma, Ewing 3Breast Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Neoplasms by Site 2Liposarcoma, Myxoid 2Histiocytoma, Malignant Fibrous 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Soft Tissue Neoplasms 1Skin Diseases 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Recurrent High Grade Meningioma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Ovarian Diseases 1

Interventions

halofantrine 2Sorafenib 2trifluridine tipiracil drug combination 1trametinib 1toripalimab 1tislelizumab 1sintilimab 1rubitecan 1repotrectinib 1pevonedistat 1pembrolizumab 1ozanimod 1lenvatinib 1ledipasvir, sofosbuvir drug combination 1gadolinium ethoxybenzyl DTPA 1fisogatinib 1ficlatuzumab 1camrelizumab 1belinostat 1avelumab 1Trabectedin 1Shadowing Technique, Histology 1Ramucirumab 1Patient Navigation 1Oxaliplatin 1Nutritional Status 1Nivolumab 1Nadroparin 1N-monoacetylcystine 1Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liver Diseases × Trabectedin × Clear all
NCT01273493 2016-02-15

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Janssen Research & Development, LLC

Phase 1 Completed
15 enrolled

Liver Diseases, Neoplasm Metastasis, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡